ATXS vs EQR · rev $706.0K vs P/E 26, $26.37B cap
Astria Therapeutics Inc (ATXS) versus Equity Residential (EQR) — a side-by-side from cached financials, not a winner call.
Astria Therapeutics Inc (ATXS) is a biotechnology company listed on US.
Equity Residential (EQR) is a reit - residential company listed on US.
Latest reported ATXS revenue for 2025-09-30 was $706.0K. Net income was -$98.4M. ATXS currently screens at market cap $382.1M.
EQR does not have a complete income-statement cache yet.
ATXS currently screens at market cap $382.1M. EQR currently screens at market cap $26.37B and trailing P/E 25.7.
Not investment advice. Open the ATXS and EQR stock pages for the full models.
Not investment advice.